Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1978-03-22
1982-08-31
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125T, A61K 3700, C07C10352
Patent
active
043472427
ABSTRACT:
Human calcitonin in the form of four components and process for their isolation from C-cells material.
REFERENCES:
Hawker, et al., Proc. Nat. Acad. Sci. (USA) 58, 1535-1539 (1967).
Tenenhouse, et al., Proc. Nat. Acad. Sci. (USA) 53, 818-822, 1965.
Putter, et al., "Calcitonin", Heinemann Med. Books London, 1968, pp. 74-76.
Potts, et al., Proc. Nat. Acad. Sci. (USA) 59, 1321-1328, 1968; 58, 328-335, 1967.
Foster, Postgrad. Med. J. 44, 411-422 (1968).
Baghdiantz, et al., Nature, 203, 1027-1028, 1964.
Haymovits, et al., Endocrinology 81, 993-1000, 1967.
M.A. Kumar, et al., J. Endocrin. 1965, 33, 469-475.
Weygand, et al., Chem. Ber. 100, 3838-3840, 1967.
Konig, et al., Chem. Ber. 101, 681-693, 1968.
Neher Robert
Riniker Bernhard
Ciba-Geigy Corporation
Collins Bruce M.
Phillips Delbert R.
LandOfFree
Hypocalcaemic peptides and process for their manufacture does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypocalcaemic peptides and process for their manufacture, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypocalcaemic peptides and process for their manufacture will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2184162